Evaluation of chidamide and PFI-1 as a combination therapy for triple-negative breast cancer

Purpose: To evaluate the in vitro and in vivo effects of the combination therapy of histone deacetylases (HDAsC) inhibitor, chidamide, and bromodomain-containing proteins (BETs) inhibitor, PFI-1, on triplenegative breast cancer (TNBC). Methods: Four distinct breast cancer cell lines and one TNBC mou...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Tropical journal of pharmaceutical research 2020-04, Vol.19 (2), p.259-264
Hauptverfasser:	Lin, Nong, Yang, Qiaolu, Xu, Tong, Shi, Lianguo
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!